Division of Functional Imaging, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Kashiwanoha 6-5-1, Kashiwa, Chiba, 277-8577, Japan.
Department of Radiology, Graduate School of Medicine, The University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo, 113-8655, Japan.
MAGMA. 2020 Oct;33(5):701-712. doi: 10.1007/s10334-020-00838-4. Epub 2020 Mar 4.
To investigate whether a SPIO-labeling technique could enable MR visualization of the treatment margin after X-irradiation at a single dose of 30 Gy.
Fifteen rats bearing N1-S1 hepatoma in either the left (group 1) or right (group 2) liver lobe were examined. Four hours after systemic SPIO administration, the left lobe was selectively irradiated at 30 Gy. Liver T2* maps were acquired 7 days later using a 9.4 T scanner. The livers were excised and examined histologically.
The irradiated area showed T2*-weighted hypointensity with significantly shorter T2* values than those in the non-irradiated area (p < 0.001). Tumors in group 1 completely disappeared, whereas tumors in group 2 had grown outside the T2*-weighted hypointensity by up to ~ 2.3 times that at baseline. Group 1 showed significantly higher probability of tumor regression than group 2 (p = 0.048). Histologically, iron deposition was heavier in irradiated areas than in non-irradiated areas.
Even at a single dose of 30 Gy, which is a slightly higher dose than can be used clinically in stereotactic body radiotherapy, MR visualization of the treatment margin was achieved, because tumors showed significant growth outside the T2*-hypointense areas. In contrast, tumors disappeared inside the T2*-hypointense areas.
研究超顺磁性氧化铁(SPIO)标记技术是否能使单次 30Gy 照射后的治疗边缘在磁共振(MR)上可视化。
在左(第 1 组)或右(第 2 组)肝叶中,各有 15 只携带 N1-S1 肝癌的大鼠接受了检查。全身给予 SPIO 后 4 小时,选择性对左叶进行 30Gy 照射。7 天后,在 9.4T 扫描仪上采集肝 T2*图。切除肝脏并进行组织学检查。
照射区域在 T2加权图像上呈低信号,T2值明显短于未照射区域(p<0.001)。第 1 组的肿瘤完全消失,而第 2 组的肿瘤在 T2*-加权低信号区域外生长,最大可达基线的 2.3 倍。第 1 组的肿瘤消退概率明显高于第 2 组(p=0.048)。组织学上,照射区域的铁沉积比未照射区域更重。
即使单次剂量为 30Gy,这略高于立体定向体放射治疗的临床应用剂量,也能通过 MR 实现治疗边缘的可视化,因为肿瘤在 T2*-低信号区域外明显生长。相比之下,肿瘤在 T2*-低信号区域内消失。